Academic Journal
Q1Drugs and Aging
About Drugs and Aging
Drugs and Aging is a scholarly journal published by its listed publisher. SCImago 2025 lists it in Q1, with an SJR of 1.354 and H-index of 119.
Coverage: 1991-2026. Research categories: Geriatrics and Gerontology (Q1); Pharmacology (medical) (Q1).
Verified field sources
- Journal Impact Factor: 4.2 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Pharmaceutical Practices and Patient Outcomes; Medication Adherence and Compliance; Dementia and Cognitive Impairment Research; Blood Pressure and Hypertension Studies; Health Systems, Economic Evaluations, Quality of Life; Heart Failure Treatment and Management.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,990.00 USD; 3,890.00 EUR; 3,090.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Correction: Effect of a Multifaceted Pharmacist-Led Intervention on Medication Appropriateness and Medication Burden in Patients Admitted to an Acute Geriatric Ward: Results from the ASPIRE Trial
Laura Hellemans, Lotte Blocquiaux, Julie Hias, Karolien Walgraeve et al.
2026-10-06 · DOI: 10.1007/s40266-026-01327-4Intravenous Iron Therapy in Very Old Adults with Heart Failure: A Frailty-Oriented Therapeutic Perspective
Rémi Esser, Marc Harboun, Marine Larbaneix, Alejandro Mondragon et al.
2026-09-30 · DOI: 10.1007/s40266-026-01339-0Patterns of Evidence-Based Medication Use in Older Adults with Chronic Heart Failure in Slovakia: A Population-Based Study Using the National Health Information Center Database
Martin Wawruch, Mariana Mrazova, Viktor Foltin, Peter Kisac et al.
2026-09-30 · DOI: 10.1007/s40266-026-01338-1Long-Term Proton Pump Inhibitor Therapy Is Common Among Older Adults: An 8-Year Finnish Nationwide Register Study
Leeni Minkkinen, Heini Kari, Fredriikka Nurminen, Juho Leppänen et al.
2026-09-30 · DOI: 10.1007/s40266-026-01335-4Medication Appropriateness and Potentially Inappropriate Medications in Older Critical Care Patients: A Scoping Review
Jessica McCann, Jen K. Jennnings, Andy Husband, Darren M. Ashcroft et al.
2026-09-28 · DOI: 10.1007/s40266-026-01333-6Risk of Dementia With Renin-Angiotensin System Inhibitors Versus Calcium Channel Blockers in Hypertensive Adults: A Nationwide Multicenter Study
Yinfang Sun, Zhixin Guo, Jinming Zhang, Mingzhen Pang et al.
2026-09-28 · DOI: 10.1007/s40266-026-01337-2Differences in Anticholinergic Exposure Assessment Across Burden Scales and Exposure Measures in a Population-Based Study: Implications for Targeted Deprescribing in Older Adults
Valentina M. Srikartika, David Youens, Rachael Moorin, Ninh Ha et al.
2026-09-15 · DOI: 10.1007/s40266-026-01336-3Creating Awareness of preScribing Cascades and Managing Adverse Drug Effects (CASC-ADE) Tool: Appraisal by Future End Users
Kjell van der Walle, Petra Denig, Toone Boerman, Fabiënne J. H. Magdelijns et al.
2026-09-09 · DOI: 10.1007/s40266-026-01334-5Longitudinal Adherence Trajectories of First-Line Nucleotide Analogues among US Older Adults with Chronic Hepatitis B
Javeria Khalid, Prasun Kumar Jalal, Jieni Li, Hua Chen et al.
2026-09-06 · DOI: 10.1007/s40266-026-01332-7Influence of Ageing on the Pharmacology, Efficacy and Safety of Oral Targeted Therapies for Inflammatory Bowel Disease: Focus on Janus Kinase (JAK) Inhibitors and Sphingosine-1-Phosphate (S1P) Receptor Modulators
Luc J. J. Derijks, Fatma Karapinar-Çarkit, Zlatan Mujagić, Rob J. van Marum et al.
2026-09 · DOI: 10.1007/s40266-026-01321-wManagement of Urinary Retention in Older Women
Rachna Sridhar, Joanna Marantidis, Anne P. Cameron
2026-08-31 · DOI: 10.1007/s40266-026-01323-8Opioids to Treat Chronic Pain in the Older Adult: A Clinical Consensus to Guarantee Safety and Avoid Adverse Events
Hugo Ribeiro, João Rocha Neves, Paulo Roberto, Catarina Cunha Sousa et al.
2026-09 · DOI: 10.1007/s40266-026-01329-2Clinical and Economic Outcomes of Korea’s National Polypharmacy Management Program for Hospitalized Older Adults: 90-Day Readmission and Healthcare Costs
Suhyun Jang, Jaeok Lim, Arum Moon, Ju-Yeun Lee et al.
2026-09 · DOI: 10.1007/s40266-026-01325-6Body Mass Index Category and the Association Between Polypharmacy and Functional Recovery in Stroke Patients: A Retrospective Cohort Study
Ayaka Matsumoto, Yoshihiro Yoshimura, Fumihiko Nagano, Sayuri Shimazu et al.
2026-09 · DOI: 10.1007/s40266-026-01326-5Loneliness and Initiation of Potentially Inappropriate Pain and Psychotropic Medications: A Retrospective Cohort Study
Rachel D. Savage, Susan E. Bronskill, Andrea Gruneir, Alexa Boblitz et al.
2026-09 · DOI: 10.1007/s40266-026-01324-7Caring for Older Adults with Acute Myeloid Leukemia: Best Practices for Aligning Patient Fitness and Preference with Available Therapies
Stephanie Franco, Christopher Wanjiku, Daniel R. Richardson
2026-08 · DOI: 10.1007/s40266-026-01318-5Associations of Polypharmacy, Diuretics and Antipsychotics with Injurious Falls: A Population-Based Cohort Study
Tewodros Yosef, Julie A. Pasco, Monica C. Tembo, Kara B. Anderson et al.
2026-09 · DOI: 10.1007/s40266-026-01320-xThe Association Between Anticholinergic Burden and Treatment-Related Complications in Older Adults with Cancer
Edwin J. Brokaar, Stella Trompet, Johanneke E. A. Portielje, Loes E. Visser et al.
2026-08 · DOI: 10.1007/s40266-026-01316-7Age-Specific Considerations in Bronchiectasis Management: Focus on Older Adults with Emphasis on Anti-inflammatory Treatment
Maria Gabriella Matera, Vito De Novellis, Raffaella Pagliaro, Vincenzo Parente et al.
2026-09 · DOI: 10.1007/s40266-026-01317-6Bronchiectasis in Older Adults: Distinctive Epidemiology, Etiology, Diagnosis, and Clinical Evolution Compared with Younger Populations
Mario Cazzola, Fabio Perrotta, Raffaella Pagliaro, Vincenzo Parente et al.
2026-09 · DOI: 10.1007/s40266-026-01322-9Reviews
Community Reviews
Version History
October 4, 2026 at 8:53 pm
September 25, 2026